跳转至内容
Merck
CN

主要文件

查看所有文档

440202

LY 294002

≥98% (HPLC), solid, PI3K inhibitor, Calbiochem®

别名:

LY 294002

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

经验公式（希尔记法）:
C19H17NO3
化学文摘社编号:
154447-36-6
分子量:
307.34
MDL number:
MFCD00270881
UNSPSC Code:
12352200
NACRES:
NA.77
Assay:
≥98% (HPLC)
Form:
solid
Quality level:
100
Storage condition:
OK to freeze, protect from light
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

LY 294002, LY294002, CAS 154447-36-6, is a cell-permeable, potent, reversible, and specific inhibitor of PI 3-kinase ((IC50 = 1.4 µM). Acts on the ATP-binding site.

Quality Level

100

assay

≥98% (HPLC)

form

solid

manufacturer/tradename

Calbiochem®

storage condition

OK to freeze, protect from light

color

off-white

solubility

DMSO: 20 mg/mL, ethanol: soluble

shipped in

ambient

storage temp.

−20°C

SMILES string

N4(CCOCC4)c1[o]c2c([c](c1)=O)cccc2c3ccccc3

InChI

1S/C19H17NO3/c21-17-13-18(20-9-11-22-12-10-20)23-19-15(7-4-8-16(17)19)14-5-2-1-3-6-14/h1-8,13H,9-12H2

InChI key

CZQHHVNHHHRRDU-UHFFFAOYSA-N

General description

一种可渗透细胞的，强效的，可逆的和特异性磷脂酰肌醇3-激酶（PI 3-激酶）抑制剂，可作用于酶的ATP结合位点（IC50 = 1.4 µ M）。还抑制460 kDa磷脂酰肌醇3样激酶DNA-PKcs中的非同源DNA末端连接（NHED），DNA-PKcs是DNA激活的蛋白激酶的催化亚基。在50 µM时不影响EGF受体激酶，MAP激酶，PKC，PI 4-激酶，S6激酶和c-src的活性。促进活性GSK-3b的核积累。据报告可抑制鼠胚胎干细胞的增殖。阻断培养的兔主动脉平滑肌细胞增殖，而不诱导凋亡。据报告可抑制RBL-2H3细胞中的组胺分泌（IC50 = 5 µM）。
一种细胞可渗透的、强效的、可逆的和特异性磷脂酰肌醇3-激酶抑制剂（IC50 = 1.4 µM），作用于酶的ATP结合位点。还抑制460 kDa磷脂酰肌醇3样激酶DNA-PKcs的非同源DNA末端连接（NHEJ）活性，DNA-PKcs是DNA激活的蛋白激酶的催化亚基。即使在50 µM时也不影响EGF受体激酶，MAP激酶，PKC，PI 4-激酶，S6激酶和c-Src的活性。促进活性GSK-3b的核积累。据报告可抑制鼠胚胎干细胞的增殖。阻断培养的兔主动脉平滑肌细胞增殖，而不诱导凋亡。显示与I-BET（目录号40101050 ~ 10 µM）结合在同一位点。也可购买10 mM（1 mg/325 µl）LY 294002（目录号440204） DMSO溶液。

Biochem/physiol Actions

主要靶标
磷脂酰肌醇3-激酶
产物与ATP竞争。
可逆性：是
细胞可渗透性：具有
靶标IC50：磷脂酰肌醇3-激酶为1.4 µM

Preparation Note

复溶后，等分并冷冻保存（-20°C）。贮备液在-20°C下可稳定保存至多6个月。
实现完全溶解可能需要轻微加热。

Other Notes

Dittman, A., et al. 2013. ACS Chem. Biol.9, 495.
Bechard, M., and Dalton.S. 2009.Mol.Cell.Biol.29, 2092.
Lianguzova, M.S. et al. 2007.Cell Biol. Int.31, 330.
Baumann, P., and West, S.C.1998.Proc.Natl.Acad.Sci. USA 95, 14066.
Cardone, M.H., et al. 1998.Science282, 1318.
Vlahos, C.J., et al. 1995.J. Immunol.154, 2413.
Yano, H., et al. 1995.Biochem.J.312, 145.
Vlahos, C.J., et al. 1994.J. Biol. Chem.269, 5241.



Selected Citations
Lee, J., et al. 2009.Cell Stem Cell5, 76.


Legal Information

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

Disclaimer

毒性：标准处理（A）

Still not finding the right product?

Explore all of our products under LY 294002

存储类别

11 - Combustible Solids

wgk

WGK 2

flash_point_f

487.4 °F

flash_point_c

253.0 °C

分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ （Lot或Batch）字后找到。

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

相关内容

Reprogramming Cell Fate and Function Novel Strategies for iPSC Generation, Characterization, and Differentiation
Human Kinome & InhibitorSelect™ Libraries

Human Kinome Poster: The InhibitorSelect™ Protein Kinase Inhibitor Libraries provide broad coverage of the human kinome as shown here. The depicted human kinome dendrogram of 518 kinases are classified into five broad groups, 90 families, and 145 subfamilies. Inhibitor coverage was assigned based upon published data related to potency (IC50, EC50, Kd, etc.) for individual kinases harvested from the literature. Colored dots denote which library contains an inhibitor with demonstrated potent activity against the designated kinase and do not necessarily reflect known specificity of the inhibitor. Coverage of lipid and atypical kinases are depicted as a separate dendrogram. As shown, Calbiochem® Protein Kinase Inhibitor Libraries cover all major kinase families including TK, CMGC, CAMK, AGC, CK1, STE, TKL, as well as Lipid or Atypical kinase families.

An Introduction to Inhibitors and Their Biological Applications - 1st Edition

An Introduction to Inhibitors and Their Biological Applications

查看所有相关内容
S E Mikkelsen et al.
Journal of neurochemistry, 79(4), 767-776 (2001-11-28)
Several members of the S100 family of Ca(2+) binding proteins are at present known to be secreted and to have extracellular activities. We have investigated the neurite inducing potential of extracellularly added S100A12. Human recombinant S100A12 was found to dramatically
Shu Qi et al.
Cancer letters, 483, 98-113 (2020-03-29)
Liver metastases remain a major cause of death from gastrointestinal tract cancers and other malignancies, such as breast and lung carcinomas. Understanding the underlying biology is essential for the design of effective therapies. We previously identified the chemokine CCL7 and
Jyoti B Kaushal et al.
Cancers, 13(13) (2021-07-03)
Niclosamide (Nic), an FDA-approved anthelmintic drug, is reported to have anti-cancer efficacy and is being assessed in clinical trials for various solid tumors. Based on its ability to target multiple signaling pathways, in the present study, we evaluated the therapeutic
查看所有相关文献

全球贸易项目编号

货号GTIN
440202-5MG07790788050290
440202-10MG04055977186666
440202-25MG04055977186673